baber/WOPTO huggingface dataset:
Patent NZ-234051-A (NZ)
Title: Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
Inventor: HIRVONEN ERKKI
IPC: A61P25/00
Filed: 1990-06-13
Abstract: The present invention relates to a pharmaceutical kit in dosage unit form for use in the treatment of postmenopausal disorders comprising separate dosage units for uninterrupted sequential daily, oral administration, said kit comprised of:   (a) 69 separate daily dosage units for sequential daily oral ingestion of a naturally occurring or synthetic estrogenic compound effective in the prevention of postmenopausal disorders; (b) 14 separate daily dosage units for sequential daily, oral ingestion of a naturally occurring or synthetic estrogenic compound and a progesterone compound having a progestational activity effective in preventing the development of endometrial hyperplasia; and (c) if desired, 6-8 separate daily dosage units for sequential daily, oral ingestion of a compound free of estrogen and progestogen. g
Patent NZ-249579-A (NZ)
Title: Apparatus for collecting and detecting antigens such as microorganisms and allergenic disease causing agents from an environment such as a household environment
Inventor: SHATTOCK ALAN GAYLARD
IPC: C12Q1/24
Filed: 1993-03-04
Abstract: PCT No. PCT/IE93/00008 Sec. 371 Date Dec. 5, 1994 Sec. 102(e) Date Dec. 5, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO93/18404 PCT Pub. Date Sep. 16, 1993An apparatus for collecting antigen, including an allergen exemplified by a dust-mite, dispersed in a motile fluid in a given environment that can be inserted in a section of a pipe of a standard vacuum cleaner hose. The apparatus includes a receptacle whose body is formed of nylon, typically with a pore size of from 15 to 60  mu m. The receptacle is coated with an antibody that retains the antigen in a contacting relationship. The apparatus is provided with a removable holder, which assists in locating the apparatus in the pipe of the vacuum cleaner. The apparatus can be used directly in an immunoassay for confirming the presence of, or quantifying, the antigen.
Patent NZ-255839-A (NZ)
Title: Process for applying chemical papermaking additives from a thin film to dry tissue paper
Inventor: AMPULSKI ROBERT STANLEY
IPC: D21H21/18
Filed: 1993-08-20
Abstract: Disclosed is a process for making soft tissue paper which includes providing a dry tissue web and then applying a sufficient amount of a chemical papermaking additive from a thin film to the dry web. The chemical papermaking additives are added to the surface of the tissue paper to enhance properties of the paper such as strength, softener, absorbency, and/or aesthetics. The chemical papermaking additive application process includes the steps of diluting the chemical papermaking additive with a suitable solvent, applying the diluted chemical solution to a heated transfer surface, evaporating the solvent from the dilute solution to form a film, and then transferring the film to the tissue by contacting the dry tissue web with the heated transfer surface. Preferably, the tissue web is dried to a moisture level below its equilibrium moisture content before application of the papermaking additive.
Patent NZ-286359-A (NZ)
Title: N-(tricyclic) amide & (thio)urea derivatives and medicaments
Inventor: LANGLOIS MICHEL
IPC: C07C231/12
Filed: 1996-04-12
Abstract: Tricyclic amides of formulae (A1) to (A4), their enantiomers and diastereoisomers, and their salts with bases are new. R1-R6 = H, halo, OH, Ra or ORa; Ra = alkyl opt. substd by one or more halo; alkenyl; alkynyl; cycloalkyl; cycloalkylalkyl; opt. substd. aryl; or opt. substd. arylalkyl; X1 = S, O, C(R5)=C(R6), C(R5)(R5)C(R6)(R6'), C(R5)(R5')C(R6)=, C(R5)(R5') or N(R14); R5', R6' = as for R1-R6; R14 = H, alkyl, opt. substd. aryl, opt. substd. arylalkyl; the dotted bond indicates that it may be single or double; Y = C(R9)(R10); R9, R10 = H, alkyl, or alkoxy; n = 1-3; R7 = H or R7'; R7' = alkyl, opt. substd. aryl or opt. substd. arylalkyl; R8 = COR11 or CSR11; R11 = R12 or NH(R13); R12, R13 = H, alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, opt. substd. aryl or opt. substd. arylalkyl; with the provisos that (a) (I) is not N-(4-methyl- 1H-2,3-dihydro phenalen-2-yl) acetamide, and (b) if X1 = NH or -N(CH3), then R1 = neither H nor halo; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; aryl = naphthyl, phenyl or pyridyl; and the opt. substits. on aryl and arylalkyl = halo, alkyl, haloalkyl, alkoxy, or OH.
Patent NZ-312791-A (NZ)
Title: Penicillaminamide derivatives
Inventor: OSHIMA MASAHIRO
IPC: C07K5/065
Filed: 1996-07-19
Abstract: Compounds represented by the general formula (I) wherein n represents 1 or 2; R<1> represents, for example, a C1-C10 alkyl group which may be substituted with a C3-C10 cycloalkyl group or carboxyl group; R<2> represents hydrogen atom, a C1-C10 alkyl group or other; and R<3> represents amino group or amidino group, whose example include trans-4-amino-Ä(S)-N-Ä(S)-2-propoxycarbonylamino-3-isopropylthio-3-met hyl-butanoylÜprolylÜaminomethylcyclohexane The compounds have potent inhibitory activity against thrombin, and are useful as anticoagulants. <CHEM>
Patent NZ-330570-A (NZ)
Title: the use of estrene steroids as neurochemical initiators of change in human hypothalamic funtion
Inventor: BERLINER DAVID
IPC: A61K31/565
Filed: 1993-09-28
Abstract: Ligands for a chemoreceptor are used in the manufacture of a medicament for altering a hypothalamic function or an autonomic function in an individual. The chemoreceptor is displayed on the surface of nasal neuroepithelial cells of the individual however the cell is not part of the olfactory epithelia tissue.  The neuroepithelial is located within a vomeronasal organ of the individual. The preferred ligand is an estrene steroid such as estra-1,3,5(10)-trien-3-ol, estra-1,3,5(10),6-tetraen-3-ol, or estra-4,16-dien-3-one.
Patent NZ-331666-A (NZ)
Title: Fraud prevention in a telecommunications network, call records compared with alarm rule
Inventor: BUSUIOC MARIUS NICOLAE
IPC: H04M3/36
Filed: 1997-03-26
Abstract: Fraudulent use of a telephone is detected by matching information on individual calls to an alarm rule.   A rule matching value is calculated dependent upon the closeness of match of the call record to the alarm rule.  A threshold Tr is defined, and if the rule matching value exceeds the threshold, an alarm is generated.  If the rule matching value is less than Tr, but is greater than a second threshold value, then the match is determined to be a near match.  The matched and near matched records are validated with an indication of expected fraud, and Tr  and the second threshold value are adjusted in dependence on the matched and near matched records.
Patent NZ-332327-A (NZ)
Title: Process for the preparation of a moisturising composition and use thereof
Inventor: CURRAN CUSHLA ROSE
Filed: 2000-01-14
Abstract: A process for preparing a moisturising composition, by preparing a homogenous mixture comprising, a) about 12 parts lecithin b) about 12 parts vegetable wax c) about 24 parts plant derived oils d) about 9.6 parts glycerine e) about 30 parts chamomile extract f) about 60 parts aloe vera gel g) about 1.2 parts tragacanth gum h) about 6 parts steryl alcohol i) about 102 parts water, including effusions of plant extracts. To this mixture is added one or more essential oils, as defined in the specification, and a preservative comprising brandy or vodka (about 0.1%v/v).
Patent NZ-336034-A (NZ)
Title: 3-nitro-imidazo[1,2-b]pyridazines substituted by alkylene-pyridine derivatives and medicaments
Inventor: GRUNDLER GERHARD
IPC: C07H15/26
Filed: 1997-12-18
Abstract: The 3-nitro-imidazo[1,2-b]pyridazines or salts or N-oxides thereof have the formula I wherein: R1 is H, optionally substituted alkyl, alkylcarbonyl, alkoxycarbonyl, sulpho (-SO3), or an optionally substituted pyrazolyl, furan, thiophene, imidazole, imidazoline, oxazole, isoxazole, thiazole, thiazoline, isothiazole, triazole, oxadiazole, thiadiazole, thiadiazole-1-oxide, tetrazole, hexanopyranose, benzene, pyridine, pyridine-N-oxide, pyridazine, pyrimidine, pyrazine, triazine, naphthalene, quinoline, quinazoline, quinoxaline, benzimidazole, benzoxazole, benzothiazole, thiazolopyridine or imidazolopyridine; R2 is H, alkyl or halogen; A is alkylene; X is absent, oxygen or sulphur; Y is oxygen, sulphur or N-alkyl and Z is oxygen or sulphur. A medicament thereof is used for the control of helicobacter bacteria.
Patent NZ-337690-A (NZ)
Title: Fluid specimen collecting and testing apparatus including a fluid releasing agent engageable within an isolation chamber
Inventor: GUIRGUIS RAOUF A
IPC: B01L3/00
Filed: 1998-02-25
Abstract: The specification describes an integrated fluid collection and testing apparatus that may be used with any type of fluid specimen.  It is particularly useful for urine, blood and saliva specimens. The apparatus collects a fluid specimen, isolates a predetermined portion of the specimen, and exposes only the isolated portion of the specimen to diagnostic or testing structures and/or reagents. The isolated portion may be isolated as the fluid is collected in the apparatus, i.e., without any additional manipulation by testing personnel. The isolated portion is then independently tested in isolation from the collected fluid specimen. Figure 3 is an exploded cut away view of the fluid specimen collecting apparatus and illustrates a preferred embodiment. The apparatus generally includes a specimen container 15, and a cover or lid 20. The specimen container 15 has an opening 25, best shown in Figure 3. It allows a fluid specimen to be placed into the container. Preferably, the specimen container 15 includes a bottom wall 50 and a generally cylindrical wall (container wall) 35 extending from the bottom wall 50. A collection chamber 40 for collecting the fluid specimen, illustrated by element 41, may be disposed within or may be defined by the walls of the specimen container 15. The collection chamber 40 may preferably include an opening 45, a bottom wall 50 and a generally cylindrical wall (collection chamber wall) 55 extending from at least a portion of the bottom wall 50. The container wall 35 preferably includes a rim 60 that extends beyond the collection chamber wall 55. The rim 60 may be threaded to accommodate a screw-on lid 20. Alternatively, the rim 60 may include a flange or lip to accommodate a snap fit lid.
Patent NZ-338101-A (NZ)
Title: Adjuvant compositions of Monophosphoryl Lipid A (MPL) and a phospholipid based surfactant (1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)) suitable for intranasal administration
Inventor: CRANE R THOMAS
IPC: A61K39/39
Filed: 1998-04-01
Abstract: An oil-free aqueous adjuvant composition comprising a 3-O-deacylated monophosphoryl A derivative and a surfactant or surfactants enhances the immunological response in a warm blooded animal to a protein antigen. A surfactant or mixtures of surfactants are dissolved in a solvant. 1,2-Dipalmitoyl-SN-glycero-3-phosphocholine is a preferred surfactant. The dissolved surfactant is added to an attenuated lipid A derivative to obtain a mixture. The molar ratio of attenuated lipid A derivative to surfactant in the mixture is about 4:1. The solvent is evaporated and water is added to the resulting film. The suspension is sonicated in a 60 DEG C water bath until it becomes clear. Animals administered the adjuvant formulation exhibited increased antibody responses to a given antigen as well as displayed enhanced lymphocyte proliferative and cytotoxic T-lymphocyte responses. Intranasal administration of the aqueous adjuvant composition and an antigen stimulates the production of serum and mucosal secreted IgA.
Patent NZ-501434-A (NZ)
Title: Video game controller, with plug-in portable game console, receives character information from controller
Inventor: SASAKI NOBUO
IPC: A63F13/12
Filed: 1999-11-30
Abstract: A portable game console 1A or 1B plugs into a video game controller.  The portable consoles contain a memory unit that stores an identification number unique to the console.  The console memory also stores games programs and programs for building a game playing character.  The game controller to which the consoles are attached stores the character's traits or "gene information" and associates them with the identification number.  When a console is plugged into the controller, the controller reads the identification number and downloads the appropriate "gene information" to the plug-in console.
Patent NZ-506965-A (NZ)
Title: Spark plug providing improved operating characteristics
Inventor: GARRETT NORMAN H
IPC: H01T13/20
Filed: 1999-03-02
Abstract: A spark plug for igniting the fuel charge of an internal combustion engine has an upwardly-extending center electrode 20 and a ground electrode 30 that defines an elongate edge that is positioned tangentially relative to the cross-sectional projection of the center electrode. The elongate edge of the ground electrode has it's lowest portion at or higher than the highest portion of the center electrode. This configuration results in increased fuel efficiency and decreased pollution.
Patent NZ-512138-A (NZ)
Title: Multilayer heat shrinkable film
Inventor: HESTBECH JENS
IPC: B29K23/00
Filed: 1999-12-03
Abstract: A multiplayer heat shrinkable film including at least: an outer layer of a thermoplastic copolymer blend including at least one ethylene alpha olefin plastomer copolymer or at least one ethylene vinyl ecetate copolymer, and a heat sealable inner layer of a thermoplastic polymer or a thermoplastic polymer blend, wherein said outer layer has a melting point at least 200 higher than said inner layer and said layers being selected to have substantially balanced shrinkage, and wherein said film is oriented to an extent selected to provide shrinkability of at least 35% in at least one of machine and transverse directions, determined by measuring unrestrained shrink of the stretched film at 900 for five seconds.
Patent NZ-514289-A (NZ)
Title: Transconnector for coupling spinal rods
Inventor: TROXELL THOMAS N
IPC: A61B17/58
Filed: 2000-03-17
Abstract: A transconnector (10) made of titanium, a titanium alloy or stainless steel for coupling first and second spinal fixation rods or other elongate fixation elements (12; 14). The transconnector (10) includes a male member (16), a female member (18), and a locking member (20). The male member (16) has a body with a linking element (22) (such as a hook) associated with the lateral end for receiving one of the fixation elements (12; 14), and a projection (24) on the medial end. The projection (24) includes a recess (32) defined by lateral and medial walls (34; 36). The female member (18) has a body with a linking element (26) associated with the lateral end for receiving the other fixation element (12; 14), and a cavity (28) with an opening (30) on the medial end for receiving a portion of the male member projection (24). The locking member (20) secures the position and orientation of the male member projection portion in the cavity (28) in order to accommodate different separation distances and orientations between the first and second fixation elements (12; 14). The locking member (20) cooperates with the medial wall of the recess (32) of the projection (24) to prevent uncoupling of the male and female members (16; 18). The male member (16) may be made as a two-component assembly in which the two components can rotate relative to one another for accommodating rod convergence or divergence.
Patent NZ-517055-A (NZ)
Title: DNA encoding a plant deoxyhypusine synthase, transgenic plants and a method for controlling senescence and programmed cell death in plants
Inventor: THOMPSON JOHN E
IPC: C12N1/21
Filed: 2000-07-06
Abstract: Regulation of expression of programmed cell death, including senescence, in plants is achieved by integration of a gene or gene fragment encoding senescence-induced deoxyhypusine synthase, senescence-induced eIF-5A or both into the plant genome in antisense orientation. Plant genes encoding senescence-induced deoxyhypusine synthase and senescence-induced eIF-5A are identified and the nucleotide sequences of each, alone and in combination are used to modify senescence in transgenic plants.
Patent NZ-517708-A (NZ)
Title: A galenically acceptable formulation of Gd-MS-325 using prepared complexes of the MS-325 ligand
Inventor: PLATZEK JOHANNES
IPC: C07F9/09
Filed: 2000-09-06
Abstract: Described is the calcium complex of [[(4R)-4- [bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9- bis[(carboxy-.kappa.O)methyl]-1-[(4,4- diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1- phosphaundecan-11-ylic-acid- .kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) and its salts. The production of pharmaceutical agents that contain these complexes for the production of agents for the reduction of effects caused by heavy metals are also described.
Patent NZ-518588-A (NZ)
Title: Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
Inventor: WEICHERT ANDREAS
IPC: A61P25/00
Filed: 2000-10-14
Abstract: The application discloses the use of the compound formula I (see below) or of its pharmaceutically tolerable salts where: R1 and R2 are hydrogen, F, Cl, Br, I strain-chain or branched C1-C4-alkyl, C1-C4-alkoxy, R3 is hydrogen, straight chain or branched C1-C4-alkyl or phenyl, the phenyl nucleus being unsubstituted or carrying one to three substituents selected from the group consisting of F, Cl, CH3 and CH3O. Formula I maybe used for the production of a medicament for the therapy of prophylaxis of ischemic conditions including, cardiac infarct, angina pectoris, and ischemic conditions of peripheral organs and limbs. It may also be used to formulate medicaments for the treatment of states of shock, for surgical operations and organ transplantation, to treat illness in which cell proliferation is a primary or secondary cause and treat prophylaxis of disorders of fat metabolism. Alternatively it may be used for the production of a medicament for the preservation and storage of transplants for surgical measures
Patent NZ-524947-A (NZ)
Title: Use of polymers as filtering aids and/or stabilizers
Inventor: DROHMANN CHRISTIAN
IPC: B01D37/02
Filed: 2001-10-13
Abstract: Filter aid, its preparation and use in filtering process is disclosed, wherein the filter aid comprises 20-95 wt.% polystyrene and 5-80 wt.% polyvinylpolypyrrolidone (PVPP) and optionally silicate, carbonate, oxide, silica gel, diatomaceous earth and/or other polymers.
Patent NZ-525326-A (NZ)
Title: Fiber cement composite materials using sized cellulose fibers
Inventor: MERKLEY DONALD J
IPC: D06M13/00
Filed: 2001-09-21
Abstract: Disclosed herein is a new technology related to cellulose fiber reinforced cement composite materials using cellulose fibers that are treated with inorganic and/or organic resins to make the fibers more hydrophobic, as well as other chemical treatments. The four aspects of the technology disclosed are: fiber treatment, formulations, methods and the final product. This technology provides fiber cement building materials with the desirable characteristics of reduced water absorption, reduced rate of water absorption, lower water migration, and lower water permeability. This technology also impart the final products improved freeze-thaw resistance, reduced efflorescence, and improved rot and UV resistances, compared to conventional fiber cement products. These improved attributes are gained without loss in dimensional stability, strength, strain or toughness. In some cases the physical and mechanical properties are improved. A method of treating cellulose fibers with various chemicals to impart the fiber hydrophobicity for applications in the fiber reinforced cement composite materials is also disclosed.
Patent NZ-525438-A (NZ)
Title: Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
Inventor: PAN WENXI
IPC: A61P29/00
Filed: 2001-10-05
Abstract: Disclosed are compounds of formula I, wherein: Y is -NH- or -O-, W is H, R1, R1OC(O), R1C(O), R1(CH2)sNHC(O), R1S(O)2, or (R1)2CH(CH2)NHC(O), B is a group selected from formula II or III, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for use as protease and thrombin inhibitors to treat diseases such as proteolysis, thrombosis, ischemia, stroke, restenosis or inflammation.
Patent NZ-532230-A (NZ)
Title: Screw anchor
Inventor: CABRELE FEDERICO
IPC: F16B13/12
Filed: 2004-04-08
Abstract: A screw anchor having an outwardly deformable central portion located between a leading head portion and a trailing collar portion, wherein four mutually spaced main longitudinal slots are formed to extend within the central portion, and a number of secondary longitudinal slots are formed to extend within the central portion and between respective main longitudinal slots, the main and secondary slots being arranged so as to form tongues which are outwardly deformable in response to a screw being driven into the anchor, and the leading head portion being free of longitudinal slots so as to resist outward deformation in response to the screw being driven into or toward the head portion.
Patent NZ-534048-A (NZ)
Title: Fire protection
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2003-02-07
Abstract: The invention relates to a wind power installation comprising a tower and a gondola disposed at the pinnacle of the tower. The invention also relates to a method for controlling such a wind power installation. Also disclosed is a first device generating an inert atmosphere so as to prevent fires or at least be able to quickly extinguish a fire.
Patent NZ-534360-A (NZ)
Title: Diagnostics and vaccines for mycobacterium paratuberculosis infections
Inventor: WILLEMSEN PETRUS THEODORUS JOH
IPC: A61K39/02
Filed: 2003-01-13
Abstract: A 9 kD Mycobacterium avium subspecies paratuberculosis protein or nucleic acid encoding such a protein. Also described is a vaccine for combating Mycobacterium avium subspecies paratuberculosis infection comprising said protein or nucleic acid.
Patent NZ-536529-A (NZ)
Title: Hazardous waste treatment method and apparatus for disposing of gas with a plasma arc
Inventor: CHAN BENJAMIN CHUN PONG
IPC: F23G5/00
Filed: 2003-05-06
Abstract: An apparatus for treating an off-gas from a waste treatment system is disclosed. The apparatus comprises of a refractory-lined cylindrical chamber having an input port (26) for receiving the off-gas, an output port and a DC powered plasma torch (18) proximate with the input port within the chamber. The torch (18) receives a working gas, the working gas including a mixture of carbon dioxide and oxygen, excluding nitrogen. The plasma torch (18) heats the chamber and the off-gas is thereby converted to an output gas, which is ejected through the output port.
Patent NZ-538570-A (NZ)
Title: A new fluorescent lamp
Inventor: CHAN KAMKWAN
IPC: H01J61/56
Filed: 2003-07-28
Abstract: A fluorescent lamp is disclosed which includes a lamp tube (1), an electronic ballast (2), and an outer tube (3) that has two ends with outer plugs (5), for respectively plugging into two lamp tube sockets (4). The electronic ballast (2) is located between one of the outer plugs (5) and the respective lamp tube socket (4), where the lamp tube (1) is located between the two lamp tube sockets (4) in the outer tube (3). The electronic ballast (2) of the lamp tube (1) includes a rectifier (10) and a high frequency inverter (20). An input of the rectifier (10) is connected to an external power supply. The rectifier (10) inverts alternating current (AC) into direct current (DC) with a required voltage, and the output of the rectifier (10) is connected to the high frequency inverter (20), where the high frequency inverter (20) inverts direct current (DC) into high frequency alternating current (AC) for supplying electrical power to said lamp.